Purpose We aimed to evaluate the prognostic value of serum anti-PLA2R and glomerular
PLA2R deposit (gPLA2R) in predicting remission of proteinuria in Primary Membranous …

Purpose The meta-analysis aims to investigate the relationship between anti-phospholipase
A2 receptor autoantibody (anti-PLA2R) and clinical characteristics and adverse outcomes of …

Introduction Primary membranous nephropathy (PMN) is associated with the anti-
phospholipase A2 receptor (anti-PLA2R) antibody in 70% of cases. Some anti-PLA2R …

The present study analyzed the clinicopathological features and prognosis in patients with
idiopathic membranous nephropathy (IMN) with hypertension. In the hypertension group …

Objective To investigate the predictors and establish a nomogram model for the prediction of
the response to treatment in primary membranous nephropathy (PMN) with nephrotic …

Background The aim of this study was to define the clinicopathologic features of
phospholipase A 2 receptor (PLA 2 R) and/or thrombospondin type-1 domain-containing 7A …

Objective The purpose of this study was to investigate the correlation between the
deposition of M-type phospholipase A2 receptor (PLA2R) in the kidney tissues of patients …

Background We aimed to evaluate cyclophosphamide efficacy in the treatment of idiopathic
membranous nephropathy (IMN) and explore the efficacy of phospholipase‐A2 receptor …

Background Membranous nephropathy (MN) represents a distinct glomerular disease which
has been considered as a major cause of nephrotic syndrome (NS) in adults. Evidences …

Membranous nephropathy (MN) is one of the most common causes of nephrotic syndrome
(NS) in nondiabetic adults, with about 70%–80% of cases of MN being primary MN (pMN) …